Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

432 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Prospective Cohort Study of Novel Markers of Hepatitis B Virus Replication in Human Immunodeficiency Virus Coinfection.
Chung RT, King WC, Ghany MG, Lisker-Melman M, Hinerman AS, Khalili M, Sulkowski M, Jain MK, Choi EK, Nalesnik MA, Bhan AK, Cloherty G, Wong DK, Sterling RK; HBV-HIV Cohort Study of the Hepatitis B Research Network. Chung RT, et al. Among authors: sulkowski m. Clin Gastroenterol Hepatol. 2023 Jan;21(1):125-135.e8. doi: 10.1016/j.cgh.2021.12.038. Epub 2021 Dec 29. Clin Gastroenterol Hepatol. 2023. PMID: 34973459 Free PMC article.
Daily versus thrice-weekly interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C in HIV-infected persons: a multicenter randomized controlled trial.
Sulkowski MS, Felizarta F, Smith C, Slim J, Berggren R, Goodman R, Ball L, Khalili M, Dieterich DT; Hepatitis Resource Network Clinical Trials Group. Sulkowski MS, et al. J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):464-72. doi: 10.1097/00126334-200404150-00004. J Acquir Immune Defic Syndr. 2004. PMID: 15021311 Clinical Trial.
Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study.
Bräu N, Fox RK, Xiao P, Marks K, Naqvi Z, Taylor LE, Trikha A, Sherman M, Sulkowski MS, Dieterich DT, Rigsby MO, Wright TL, Hernandez MD, Jain MK, Khatri GK, Sterling RK, Bonacini M, Martyn CA, Aytaman A, Llovet JM, Brown ST, Bini EJ; North American Liver Cancer in HIV Study Group. Bräu N, et al. Among authors: sulkowski ms. J Hepatol. 2007 Oct;47(4):527-37. doi: 10.1016/j.jhep.2007.06.010. Epub 2007 Jul 19. J Hepatol. 2007. PMID: 17692986
Viral hepatitis and HIV coinfection.
Sulkowski MS. Sulkowski MS. J Hepatol. 2008 Feb;48(2):353-67. doi: 10.1016/j.jhep.2007.11.009. Epub 2007 Dec 4. J Hepatol. 2008. PMID: 18155314 Review.
Lessons from HIV therapy applied to viral hepatitis therapy: summary of a workshop.
Monto A, Schooley RT, Lai JC, Sulkowski MS, Chung RT, Pawlotsky JM, McHutchison JG, Jacobson IM. Monto A, et al. Among authors: sulkowski ms. Am J Gastroenterol. 2010 May;105(5):989-1004; quiz 988, 1005. doi: 10.1038/ajg.2009.726. Epub 2010 Jan 19. Am J Gastroenterol. 2010. PMID: 20087331 Review.
Hepatitis C virus treatment-related anemia is associated with higher sustained virologic response rate.
Sulkowski MS, Shiffman ML, Afdhal NH, Reddy KR, McCone J, Lee WM, Herrine SK, Harrison SA, Poordad FF, Koury K, Deng W, Noviello S, Pedicone LD, Brass CA, Albrecht JK, McHutchison JG; IDEAL Study Team. Sulkowski MS, et al. Gastroenterology. 2010 Nov;139(5):1602-11, 1611.e1. doi: 10.1053/j.gastro.2010.07.059. Epub 2010 Aug 16. Gastroenterology. 2010. PMID: 20723545 Clinical Trial.
Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patients.
Vachon ML, Factor SH, Branch AD, Fiel MI, Rodriguez-Torres M, Bräu N, Sterling RK, Slim J, Talal AH, Dieterich DT, Sulkowski MS. Vachon ML, et al. Among authors: sulkowski ms. J Hepatol. 2011 Jan;54(1):41-7. doi: 10.1016/j.jhep.2010.06.025. Epub 2010 Aug 21. J Hepatol. 2011. PMID: 20974502 Free PMC article. Clinical Trial.
Hepatitis C pharmacogenetics: state of the art in 2010.
Afdhal NH, McHutchison JG, Zeuzem S, Mangia A, Pawlotsky JM, Murray JS, Shianna KV, Tanaka Y, Thomas DL, Booth DR, Goldstein DB; Pharmacogenetics and Hepatitis C Meeting Participants. Afdhal NH, et al. Hepatology. 2011 Jan;53(1):336-45. doi: 10.1002/hep.24052. Hepatology. 2011. PMID: 21254181 Review.
Racial differences in hepatitis C treatment eligibility.
Melia MT, Muir AJ, McCone J, Shiffman ML, King JW, Herrine SK, Galler GW, Bloomer JR, Nunes FA, Brown KA, Mullen KD, Ravendhran N, Ghalib RH, Boparai N, Jiang R, Noviello S, Brass CA, Albrecht JK, McHutchison JG, Sulkowski MS; IDEAL Study Team. Melia MT, et al. Hepatology. 2011 Jul;54(1):70-8. doi: 10.1002/hep.24358. Hepatology. 2011. PMID: 21488082 Free PMC article.
432 results